ABCL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 28.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

AbCellera Biologics Insider Trading History Chart

AbCellera Biologics Share Price & Price History

^$2.64

▼ -0.08 (-2.94%)

As of 11/8/2024 01:57 PM ET

Days: 30 | 90 | 365

Urgent: This election is rigged

From Porter & Company | Ad

I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the assets that could help you create wealth from these events, even as so many others watch their portfolios destroyed.

Everything you need to know is here in my emergency broadcast.

AbCellera Biologics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/26/2023	Andrew Booth	CFO	Buy	14,500	$6.85	$99,325.00	153,000
5/26/2023	Holdings Ltd. Thermopylae	Major Shareholder	Buy	153,000	$6.52	$997,560.00	56,012,493
12/16/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	85,102	$10.10	$859,530.20	55,859,493
8/19/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	200,000	$11.46	$2,292,000.00	55,844,391
6/13/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	54,915	$8.03	$440,967.45	55,635,218
6/6/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	64,545	$7.50	$484,087.50	55,580,303
5/16/2022	Veronique Lecault	COO	Buy	200,000	$6.34	$1,268,000.00	1,770,122
5/12/2022	Andrew Booth	CFO	Buy	85,000	$5.79	$492,150.00	138,500
5/12/2022	Holdings Ltd. Thermopylae	Major Shareholder	Buy	1,408,468	$6.41	$9,028,279.88	55,215,758
3/4/2022	John S. Montalbano	Director	Buy	10,000	$8.54	$85,400.00
3/1/2022	John S. Montalbano	Director	Buy	20,000	$9.05	$181,000.00
2/28/2022	Veronique Lecault	COO	Buy	230,789	$8.66	$1,998,632.74
12/3/2021	Andrew Lo	Director	Buy	86,938	$14.02	$1,218,870.76
11/11/2021	Andrew Booth	CFO	Buy	53,500	$14.74	$788,590.00
11/11/2021	Holdings Ltd. Thermopylae	Major Shareholder	Buy	202,960	$14.76	$2,995,689.60

“This Changes Everything” - Trump Hands Millions Massive IRS Gift

From Colonial Metals | Ad

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

SEC Filings (Institutional Ownership Changes) for AbCellera Biologics (NASDAQ:ABCL)

61.42% of AbCellera Biologics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbCellera Biologics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/7/2024	Clarkston Capital Partners LLC	22,000	$57K	0.0%	N/A	0.007%
11/6/2024	Pier 88 Investment Partners LLC	195,500	$0.51M	0.1%	+21.0%	0.066%
11/5/2024	Baillie Gifford & Co.	12,894,703	$33.53M	0.0%	-41.1%	4.376%
11/5/2024	GSA Capital Partners LLP	241,866	$0.63M	0.0%	+991.3%	0.082%
11/1/2024	Resolute Advisors LLC	61,576	$0.16M	0.0%	+7.0%	0.021%
10/29/2024	Arcadia Investment Management Corp MI	10,000	$26K	0.0%	N/A	0.003%
10/25/2024	China Universal Asset Management Co. Ltd.	56,674	$0.15M	0.0%	+64.1%	0.019%
10/23/2024	Ballentine Partners LLC	20,732	$54K	0.0%	N/A	0.007%
10/22/2024	Signaturefd LLC	35,659	$93K	0.0%	+244.0%	0.012%
10/15/2024	NBC Securities Inc.	11,420	$29K	0.0%	+56.0%	0.004%
10/11/2024	Creative Planning	35,799	$93K	0.0%	N/A	0.012%
10/7/2024	Green Alpha Advisors LLC	48,515	$0.13M	0.1%	+96.3%	0.016%
9/5/2024	Sanctuary Advisors LLC	105,924	$0.31M	0.0%	N/A	0.036%
8/19/2024	B. Riley Wealth Advisors Inc.	21,500	$64K	0.0%	+104.8%	0.007%
8/15/2024	Dark Forest Capital Management LP	146,001	$0.43M	0.1%	+45.6%	0.050%
8/14/2024	Squarepoint Ops LLC	68,908	$0.20M	0.0%	+47.3%	0.023%
8/14/2024	Evergreen Capital Management LLC	10,685	$32K	0.0%	N/A	0.004%
8/13/2024	Skandinaviska Enskilda Banken AB publ	308,567	$0.91M	0.0%	+104.9%	0.105%
8/12/2024	XTX Topco Ltd	33,590	$99K	0.0%	N/A	0.011%
8/12/2024	Hsbc Holdings PLC	21,497	$63K	0.0%	-76.1%	0.007%
8/9/2024	Renaissance Technologies LLC	1,728,603	$5.12M	0.0%	+16.0%	0.588%
8/9/2024	Citizens Financial Group Inc. RI	311,890	$0.92M	0.0%	N/A	0.106%
8/8/2024	Federated Hermes Inc.	2,726,016	$8.07M	0.0%	-3.2%	0.927%
8/7/2024	Headlands Technologies LLC	49,393	$0.15M	0.0%	N/A	0.017%
8/6/2024	Pier 88 Investment Partners LLC	161,620	$0.48M	0.1%	+362.0%	0.055%
7/26/2024	Signature Estate & Investment Advisors LLC	39,668	$0.12M	0.0%	N/A	0.013%
7/25/2024	Baillie Gifford & Co.	21,911,014	$64.86M	0.1%	-5.5%	7.451%
7/19/2024	Intellectus Partners LLC	545,533	$1.62M	0.4%	+0.7%	0.186%
5/16/2024	B. Riley Wealth Advisors Inc.	10,500	$48K	0.0%	-46.2%	0.004%
5/15/2024	Baker BROS. Advisors LP	27,525,640	$124.69M	1.6%	+20.1%	9.361%
5/15/2024	Lazard Asset Management LLC	2,020,012	$9.15M	0.0%	-40.8%	0.687%
5/14/2024	Nan Fung Group Holdings Ltd	50,971	$0.23M	0.2%	+307.1%	0.017%
5/9/2024	State Board of Administration of Florida Retirement System	52,800	$0.24M	0.0%	N/A	0.018%
5/6/2024	Duality Advisers LP	68,099	$0.31M	0.0%	-38.7%	0.023%
5/2/2024	Seelaus Asset Management LLC	15,000	$68K	0.1%	N/A	0.005%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	100,145	$0.45M	0.0%	N/A	0.034%
5/1/2024	Baillie Gifford & Co.	23,180,089	$105.01M	0.1%	-3.6%	7.917%
4/29/2024	Principal Financial Group Inc.	34,204	$0.16M	0.0%	-69.2%	0.012%
4/29/2024	China Universal Asset Management Co. Ltd.	56,306	$0.26M	0.0%	+67.7%	0.019%
4/22/2024	PFG Investments LLC	16,600	$75K	0.0%	N/A	0.006%
4/15/2024	TrueMark Investments LLC	109,957	$0.50M	0.5%	+13.5%	0.038%
4/12/2024	Pacifica Partners Inc.	8,619	$39K	0.0%	+78.8%	0.003%
3/15/2024	B. Riley Wealth Advisors Inc.	19,500	$0.11M	0.0%	+85.7%	0.007%
2/13/2024	Tower Research Capital LLC TRC	6,285	$36K	0.0%	-25.8%	0.002%
2/13/2024	Capital World Investors	8,351,293	$47.69M	0.0%	-0.8%	2.878%
2/9/2024	Aigen Investment Management LP	15,724	$90K	0.0%	-81.9%	0.005%
2/8/2024	Vanguard Personalized Indexing Management LLC	14,259	$81K	0.0%	N/A	0.005%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	38,855	$0.22M	0.0%	+13.6%	0.013%
2/7/2024	Principal Financial Group Inc.	111,188	$0.64M	0.0%	+19.6%	0.038%
2/7/2024	Jump Financial LLC	247,597	$1.41M	0.0%	-9.8%	0.085%
2/5/2024	Intellectus Partners LLC	887,283	$5.07M	1.5%	+1.2%	0.306%
2/1/2024	Duality Advisers LP	111,041	$0.63M	0.1%	-31.5%	0.038%
2/1/2024	Handelsbanken Fonder AB	45,400	$0.26M	0.0%	+13.5%	0.016%
2/1/2024	Signaturefd LLC	10,596	$61K	0.0%	+306.3%	0.004%
1/31/2024	Federated Hermes Inc.	3,117,680	$17.80M	0.0%	-4.2%	1.074%
1/26/2024	Baillie Gifford & Co.	24,044,796	$137.30M	0.1%	-8.2%	8.286%
1/24/2024	Stratos Wealth Advisors LLC	43,500	$0.25M	0.0%	-10.3%	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	33,566	$0.19M	0.0%	+352.2%	0.012%
1/19/2024	JGP Global Gestao de Recursos Ltda.	17,417	$99K	0.1%	N/A	0.006%
1/16/2024	Raymond James Financial Services Advisors Inc.	10,935	$62K	0.0%	N/A	0.004%
1/16/2024	Raymond James & Associates	12,386	$71K	0.0%	-23.2%	0.004%
1/12/2024	Cedar Brook Financial Partners LLC	39,668	$0.22M	0.0%	+31.1%	0.014%
1/11/2024	TrueMark Investments LLC	96,853	$0.55M	0.6%	N/A	0.033%
1/8/2024	Pacifica Partners Inc.	4,820	$28K	0.0%	+82.9%	0.002%
1/5/2024	Green Alpha Advisors LLC	27,827	$0.16M	0.1%	-29.3%	0.010%
12/1/2023	B. Riley Wealth Advisors Inc.	10,500	$48K	0.0%	N/A	0.004%
11/30/2023	American Century Companies Inc.	954,623	$4.39M	0.0%	-14.2%	0.329%
11/22/2023	Graham Capital Management L.P.	180,389	$0.83M	0.0%	+149.4%	0.062%
11/15/2023	GSA Capital Partners LLP	146,190	$0.67M	0.1%	+1,268.1%	0.050%
11/15/2023	AXQ Capital LP	27,000	$0.12M	0.0%	N/A	0.009%
11/15/2023	Stansberry Asset Management LLC	112,467	$0.52M	0.1%	+9.5%	0.039%
11/14/2023	Lazard Asset Management LLC	3,146,833	$14.48M	0.0%	-3.9%	1.084%
11/14/2023	Schonfeld Strategic Advisors LLC	358,400	$1.65M	0.0%	+143.1%	0.124%
11/14/2023	Trexquant Investment LP	272,158	$1.25M	0.0%	+458.5%	0.094%
11/13/2023	Algert Global LLC	30,100	$0.14M	0.0%	N/A	0.010%
11/13/2023	Federated Hermes Inc.	3,254,353	$14.97M	0.0%	-3.5%	1.122%
11/13/2023	Dark Forest Capital Management LP	278,618	$1.28M	0.1%	+199.6%	0.096%
11/13/2023	Aigen Investment Management LP	86,795	$0.40M	0.1%	N/A	0.030%
11/13/2023	Baillie Gifford & Co.	26,204,649	$120.54M	0.1%	-0.6%	9.031%
11/9/2023	Skandinaviska Enskilda Banken AB publ	83,867	$0.39M	0.0%	+3.7%	0.029%
11/8/2023	Pathstone Family Office LLC	17,390	$80K	0.0%	+16.5%	0.006%
11/8/2023	Janney Montgomery Scott LLC	19,064	$88K	0.0%	N/A	0.007%
11/7/2023	Barclays PLC	20,986	$97K	0.0%	-96.0%	0.007%
11/7/2023	Cookson Peirce & Co. Inc.	20,000	$92K	0.0%	N/A	0.007%
11/7/2023	Jump Financial LLC	274,502	$1.26M	0.0%	-28.1%	0.095%
11/4/2023	NBC Securities Inc.	6,720	$30K	0.0%	N/A	0.002%
11/2/2023	Principal Financial Group Inc.	92,971	$0.43M	0.0%	+28.2%	0.032%
11/2/2023	Duality Advisers LP	162,200	$0.75M	0.1%	+30.4%	0.056%
10/31/2023	China Universal Asset Management Co. Ltd.	7,423	$34K	0.0%	+96.1%	0.003%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	62,759	$0.29M	0.0%	+33.8%	0.022%
10/24/2023	Stratos Wealth Advisors LLC	48,500	$0.22M	0.0%	N/A	0.017%
10/24/2023	Raymond James & Associates	16,132	$74K	0.0%	-69.5%	0.006%
10/17/2023	Cedar Brook Financial Partners LLC	30,250	$0.14M	0.0%	+19.8%	0.010%
10/11/2023	Vontobel Holding Ltd.	10,003	$46K	0.0%	N/A	0.003%
10/10/2023	Green Alpha Advisors LLC	39,364	$0.18M	0.1%	-27.7%	0.014%
10/10/2023	National Bank of Canada FI	6,085	$27K	0.0%	+392.7%	0.002%
9/21/2023	Barclays PLC	525,964	$3.40M	0.0%	+1.0%	0.182%
8/23/2023	CTC Alternative Strategies Ltd.	18,100	$0.12M	0.1%	N/A	0.006%
8/14/2023	Ergoteles LLC	418,902	$2.71M	0.1%	+1,095.2%	0.145%
8/14/2023	ArrowMark Colorado Holdings LLC	4,105,095	$26.52M	0.3%	N/A	1.419%

Data available starting January 2016

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

Today's Range

Now: $2.64

$2.63

$2.74

50 Day Range

MA: $2.63

$2.39

$2.89

52 Week Range

Now: $2.64

$2.34

$6.05

Volume

1,180,923 shs

Average Volume

1,633,271 shs

Market Capitalization

$777.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of AbCellera Biologics?: AbCellera Biologics' top insider shareholders include:
Holdings Ltd Thermopylae (Major Shareholder)
Andrew Booth (CFO)
Learn More about top insider investors at AbCellera Biologics.
Who are the major institutional investors of AbCellera Biologics?: AbCellera Biologics' top institutional shareholders include:
Baillie Gifford & Co. — 4.38%
GSA Capital Partners LLP — 0.08%
Pier 88 Investment Partners LLC — 0.07%
Resolute Advisors LLC — 0.02%
China Universal Asset Management Co. Ltd. — 0.02%
Green Alpha Advisors LLC — 0.02%
Learn More about top institutional investors of AbCellera Biologics stock.
Which major investors are selling AbCellera Biologics stock?: Within the last quarter, ABCL stock was sold by these institutional investors:
Baillie Gifford & Co.
Which major investors are buying AbCellera Biologics stock?: In the last quarter, ABCL stock was purchased by institutional investors including:
GSA Capital Partners LLP
Creative Planning
Pier 88 Investment Partners LLC
Signaturefd LLC
Green Alpha Advisors LLC
China Universal Asset Management Co. Ltd.
Clarkston Capital Partners LLC
Ballentine Partners LLC
Within the previous year, these company insiders have bought AbCellera Biologics stock:
Holdings Ltd Thermopylae (Major Shareholder)
Andrew Booth (CFO)
Learn More investors buying AbCellera Biologics stock.